BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26027865)

  • 1. Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model.
    Barba-Recreo P; Del Castillo Pardo de Vera JL; Georgiev-Hristov T; Ruiz Bravo-Burguillos E; Abarrategi A; Burgueño M; García-Arranz M
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1161-8. PubMed ID: 26027865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
    Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
    Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
    Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
    J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
    Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
    Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis.
    Silva PG; Ferreira Junior AE; Teófilo CR; Barbosa MC; Lima Júnior RC; Sousa FB; Mota MR; Ribeiro Rde A; Alves AP
    Arch Oral Biol; 2015 Sep; 60(9):1237-45. PubMed ID: 26093347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats.
    Zandi M; Dehghan A; Ghadermazi K; Malekzadeh H; Akbarzadeh M
    J Craniomaxillofac Surg; 2015 Nov; 43(9):1823-8. PubMed ID: 26355024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.
    Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S
    J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years.
    Mücke T; Deppe H; Hein J; Wolff KD; Mitchell DA; Kesting MR; Retz M; Gschwend JE; Thalgott M
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1689-1693. PubMed ID: 27555374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronate induces osteonecrosis of the jaw in sheep.
    Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
    Martins MA; Martins MD; Lascala CA; Curi MM; Migliorati CA; Tenis CA; Marques MM
    Oral Oncol; 2012 Jan; 48(1):79-84. PubMed ID: 21940198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological features of bisphosphonates related osteonecrosis of the jaw in rats with and without vitamin d supplementation.
    Yanık S; Aras MH; Erkılıç S; Bozdağ Z; Demir T; Çetiner S
    Arch Oral Biol; 2016 May; 65():59-65. PubMed ID: 26854621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental investigation of relationship between trauma and bisphosphonate-related osteonecrosis.
    Agaçayak KS; Yuksel H; Atilgan S; Koparal M; Uçan MC; Ozgöz M; Yaman F; Atalay Y; Acikan I
    Niger J Clin Pract; 2014; 17(5):559-64. PubMed ID: 25244263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the therapeutic effects of conditioned media from mesenchymal stem cells in a rat bisphosphonate-related osteonecrosis of the jaw-like model.
    Ogata K; Katagiri W; Osugi M; Kawai T; Sugimura Y; Hibi H; Nakamura S; Ueda M
    Bone; 2015 May; 74():95-105. PubMed ID: 25613174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial promotion of bisphosphonate-induced osteonecrosis in Wistar rats.
    Tsurushima H; Kokuryo S; Sakaguchi O; Tanaka J; Tominaga K
    Int J Oral Maxillofac Surg; 2013 Nov; 42(11):1481-7. PubMed ID: 23932020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell therapy in bisphosphonate-related osteonecrosis of the jaw.
    Gonzálvez-García M; Rodríguez-Lozano FJ; Villanueva V; Segarra-Fenoll D; Rodríguez-González MA; Oñate-Sánchez R; Blanquer M; Moraleda JM
    J Craniofac Surg; 2013 May; 24(3):e226-8. PubMed ID: 23714970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats.
    Li CL; Lu WW; Seneviratne CJ; Leung WK; Zwahlen RA; Zheng LW
    Clin Oral Implants Res; 2016 Jan; 27(1):1-6. PubMed ID: 25371026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
    Del Fabbro M; Gallesio G; Mozzati M
    Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: technical report.
    Soydan SS; Uckan S
    J Oral Maxillofac Surg; 2014 Feb; 72(2):322-6. PubMed ID: 24075235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw.
    Abtahi J; Agholme F; Sandberg O; Aspenberg P
    J Dent Res; 2013 Mar; 92(3):279-83. PubMed ID: 23264610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.